Increased expression of interleukin-22 in patients with giant cell arteritis
Tóm tắt
Từ khóa
Tài liệu tham khảo
2012, Clinical features of polymyalgia rheumatica and giant cell arteritis, Nat Rev Rheumatol, 8, 509, 10.1038/nrrheum.2012.97
2008, Polymyalgia rheumatica and giant-cell arteritis, Lancet, 372, 234, 10.1016/S0140-6736(08)61077-6
2016, Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis, Joint Bone Spine, 84, 421
2013, Immune mechanisms in medium and large-vessel vasculitis, Nat Rev Rheumatol, 9, 731, 10.1038/nrrheum.2013.161
2010, Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces, Adv Immunol, 107, 1, 10.1016/B978-0-12-381300-8.00001-0
2010, Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection, Cytokine Growth Factor Rev, 21, 365, 10.1016/j.cytogfr.2010.08.002
2016, Biological and pathological activities of interleukin-22, J Mol Med, 94, 523, 10.1007/s00109-016-1391-6
2004, Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis, Rheumatology, 43, 294
2010, Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis, Arthritis Care Res, 62, 835, 10.1002/acr.20043
1993, Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis, Arthritis Rheum, 36, 1286, 10.1002/art.1780360913
2012, Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis, Arthritis Rheum, 64, 2001, 10.1002/art.34327
2011, Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis, Circulation, 123, 309, 10.1161/CIRCULATIONAHA.110.936203
2014, Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations, Am J Surg Pathol, 38, 1360, 10.1097/PAS.0000000000000244
1990, The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthritis Rheum, 33, 1122, 10.1002/art.1780330810
2014, Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity, Rheumatology, 53, 1307, 10.1093/rheumatology/keu005
2017, Ectopic expression of CXCL13, BAFF, APRIL and LT-beta is associated with artery tertiary lymphoid organs in giant cell arteritis, Ann Rheum Dis, 76, 235, 10.1136/annrheumdis-2016-209217
2008, Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis, Ann Rheum Dis, 67, 1581, 10.1136/ard.2007.070805
2015, IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs, Proc Natl Acad Sci U S A, 112, 11024, 10.1073/pnas.1503315112
2015, Th1 and Th17 cytokines drive inflammation in Takayasu arteritis, Arthritis Rheumatol, 67, 1353, 10.1002/art.39037
2016, Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling, Sci Signal, 9, ra28, 10.1126/scisignal.aad2357
2014, Therapeutic opportunities of the IL-22–IL-22R1 system, Nat Rev Drug Discov, 13, 21, 10.1038/nrd4176
2015, Th22 cells contribution in immunopathogenesis of rheumatic diseases, Iran J Allergy Asthma Immunol, 14, 246
2012, Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome, Ann Rheum Dis, 71, 295, 10.1136/ard.2011.154013
2013, Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome, PLoS One, 8, e71466, 10.1371/journal.pone.0071466
2015, IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice, Atherosclerosis, 242, 506, 10.1016/j.atherosclerosis.2015.08.006